)
Esperion Therapeutics (ESPR) investor relations material
Esperion Therapeutics Proxy filing summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Executive summary
Annual meeting scheduled for May 28, 2026, with virtual participation available for shareholders.
Shareholders are encouraged to review proxy materials online or request copies by May 14, 2026.
Voting matters and shareholder proposals
Election of two Class I directors: J. Martin Carroll and Sheldon L. Koenig.
Advisory vote on executive compensation (say-on-pay) is on the agenda.
Ratification of Ernst & Young LLP as independent auditor for fiscal year ending December 31, 2026.
Proposal to amend the 2022 Stock Option and Incentive Plan.
Proxies may vote on other business arising at the meeting or any adjournment.
Board of directors and corporate governance
Board recommends voting in favor of all proposals and director nominees.
- Shareholders will vote on director elections, executive pay, auditor ratification, and a major equity plan amendment.ESPR
Proxy filing16 Apr 2026 - Acquisition of Corstasis and new guidelines drive growth and pipeline momentum.ESPR
25th Annual Needham Virtual Healthcare Conference13 Apr 2026 - Revenue growth, Corstasis acquisition, and pipeline advances drive long-term expansion.ESPR
The Citizens Life Sciences Conference 202611 Mar 2026 - Record revenue, global expansion, and Corstasis acquisition drive 2026 profitability outlook.ESPR
Q4 202510 Mar 2026 - Strong commercial growth, pipeline innovation, and global expansion drive long-term ambitions.ESPR
Corporate presentation10 Mar 2026 - Acquisition brings a novel FDA-approved nasal spray diuretic, targeting a $5B market.ESPR
M&A announcement4 Mar 2026 - Label expansion and payer wins drive strong growth in primary prevention and financial stability.ESPR
Goldman Sachs 45th Annual Global Healthcare Conference1 Feb 2026 - Label expansion and payer updates drive growth, with profitability targeted by early 2025.ESPR
Jefferies Global Healthcare Conference1 Feb 2026 - Q2 revenue up 186% year-over-year, with liquidity and global expansion driving future growth.ESPR
Q2 20241 Feb 2026
Next Esperion Therapeutics earnings date
Next Esperion Therapeutics earnings date
The essential earnings season companion
The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
I can't remember the last time an app had such a positive impact on my investment process.
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
I can't remember the last time an app had such a positive impact on my investment process.
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
)
)
)
Frequently asked questions
Explore our global coverage